Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply.
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply. Aliment Pharmacol Ther. 2018 05; 47(10):1423-1424.